Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2008 2
2009 1
2010 2
2011 6
2012 4
2013 4
2015 1
2016 1
2017 1
2018 5
2019 8
2020 9
2021 11
2022 16
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease.
Salas A, Hernandez-Rocha C, Duijvestein M, Faubion W, McGovern D, Vermeire S, Vetrano S, Vande Casteele N. Salas A, et al. Among authors: duijvestein m. Nat Rev Gastroenterol Hepatol. 2020 Jun;17(6):323-337. doi: 10.1038/s41575-020-0273-0. Epub 2020 Mar 19. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32203403 Review.
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease.
Verstockt B, Vetrano S, Salas A, Nayeri S, Duijvestein M, Vande Casteele N; Alimentiv Translational Research Consortium (ATRC). Verstockt B, et al. Among authors: duijvestein m. Nat Rev Gastroenterol Hepatol. 2022 Jun;19(6):351-366. doi: 10.1038/s41575-021-00574-7. Epub 2022 Feb 14. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35165437 Review.
Reply.
Straatmijer T, Van Der Meulen AE, Duijvestein M. Straatmijer T, et al. Among authors: duijvestein m. Clin Gastroenterol Hepatol. 2023 May;21(5):1373-1374. doi: 10.1016/j.cgh.2022.07.040. Epub 2022 Aug 10. Clin Gastroenterol Hepatol. 2023. PMID: 35961519 No abstract available.
[Inflammatory bowel disease].
Straatmijer T, Duijvestein M. Straatmijer T, et al. Among authors: duijvestein m. Ned Tijdschr Geneeskd. 2023 Aug 31;167:D7680. Ned Tijdschr Geneeskd. 2023. PMID: 37707443 Dutch.
Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study.
Straatmijer T, Biemans VBC, Visschedijk M, Hoentjen F, de Vries A, van Bodegraven AA, Bodelier A, de Boer NKH, Dijkstra G, Festen N, Horjus C, Jansen JM, Jharap B, Mares W, van Schaik FDM, Ponsioen C, Romkens T, Srivastava N, van der Voorn MMPJA, West R, van der Woude J, Wolvers MDJ, Pierik M, van der Meulen-de Jong AE, Duijvestein M; Initiative on Crohn and Colitis. Straatmijer T, et al. Among authors: duijvestein m. Clin Gastroenterol Hepatol. 2023 Jan;21(1):182-191.e2. doi: 10.1016/j.cgh.2022.04.038. Epub 2022 May 26. Clin Gastroenterol Hepatol. 2023. PMID: 35644343 Free article.
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial.
Löwenberg M, Volkers A, van Gennep S, Mookhoek A, Montazeri N, Clasquin E, Duijvestein M, van Bodegraven A, Rietdijk S, Jansen J, van Asseldonk D, van der Zanden E, Dijkgraaf M, West R, de Boer N, D'Haens G. Löwenberg M, et al. Among authors: duijvestein m. J Crohns Colitis. 2023 Jul 5;17(7):1055-1065. doi: 10.1093/ecco-jcc/jjad022. J Crohns Colitis. 2023. PMID: 36847130 Free PMC article. Clinical Trial.
Steps Toward a Greener Endoscopy Unit.
de Jong D, Volkers A, de Ridder E, Neijenhuis M, Duijvestein M. de Jong D, et al. Among authors: duijvestein m. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2723-2726.e2. doi: 10.1016/j.cgh.2023.06.007. Epub 2023 Jun 16. Clin Gastroenterol Hepatol. 2023. PMID: 37330119 Free article. No abstract available.
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
Straatmijer T, Biemans VBC, Moes DJAR, Hoentjen F, Ter Heine R, Maljaars PWJ, Theeuwen R, Pierik M, Duijvestein M, van der Meulen-de Jong AE; Dutch Initiative on Crohn’s and Colitis (ICC). Straatmijer T, et al. Among authors: duijvestein m. Dig Dis Sci. 2023 Jun;68(6):2647-2657. doi: 10.1007/s10620-023-07822-7. Epub 2023 Mar 15. Dig Dis Sci. 2023. PMID: 36920666 Free PMC article.
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.
Volkers A, Straatmijer T, Duijvestein M, Sales A, Levran A, van Schaik F, Maljaars J, Gecse K, Ponsioen C, Grootjans J, Hanzel J, Tack G, Jansen J, Hoentjen F, de Boer N, van der Marel S, Dijkstra G, Oldenburg B, Löwenberg M, van der Meulen A, D Haens G; IBD center Amsterdam and the Dutch Initiative on Crohn and Colitis. Volkers A, et al. Among authors: duijvestein m. Aliment Pharmacol Ther. 2022 Sep;56(6):1044-1054. doi: 10.1111/apt.17153. Epub 2022 Jul 23. Aliment Pharmacol Ther. 2022. PMID: 35869807 Free PMC article.
78 results